Literature DB >> 23562924

Fine tuning risk stratification for atrial fibrillation.

Richard W Troughton, Ian Crozier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23562924     DOI： 10.1016/j.jacc.2013.02.066

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

Review 1.  Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Authors:  Daniel Hammersley; Mark Signy
Journal:  Ther Adv Chronic Dis       Date:  2017-07-26       Impact factor: 5.091

Review 2.  Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.

Authors:  Rose Mary Ferreira Lisboa da Silva
Journal:  Curr Atheroscler Rep       Date:  2017-01       Impact factor: 5.113

Review 3.  New Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

Authors:  Fatima Urooj; Abhishek Kulkarni; Dwight Stapleton; Edo Kaluski
Journal:  Clin Cardiol       Date:  2016-10-07       Impact factor: 2.882

4.  Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.

Authors:  Motoyuki Nakamura; Yorihiko Koeda; Fumitaka Tanaka; Toshiyuki Onoda; Kazuyoshi Itai; Masaki Ohsawa; Kozo Tanno; Kiyomi Sakata; Shinich Omama; Yasuhiro Ishibashi; Shinji Makita; Mutsuko Ohta; Kuniaki Ogasawara; Takashi Komatsu; Akira Okayama
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.